These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. Wang XL; Xu R; Lu ZR J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104 [TBL] [Abstract][Full Text] [Related]
6. Chitosan Nanoparticles for SiRNA Delivery In Vitro. Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448 [TBL] [Abstract][Full Text] [Related]
7. Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy. Wang C; Xia Y; Huo S; Shou D; Mei Q; Tang W; Li Y; Liu H; Zhou Y; Zhu B Int J Nanomedicine; 2020; 15():9759-9770. PubMed ID: 33304100 [TBL] [Abstract][Full Text] [Related]
8. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579 [TBL] [Abstract][Full Text] [Related]
9. Sustained small interfering RNA delivery by mesoporous silicon particles. Tanaka T; Mangala LS; Vivas-Mejia PE; Nieves-Alicea R; Mann AP; Mora E; Han HD; Shahzad MM; Liu X; Bhavane R; Gu J; Fakhoury JR; Chiappini C; Lu C; Matsuo K; Godin B; Stone RL; Nick AM; Lopez-Berestein G; Sood AK; Ferrari M Cancer Res; 2010 May; 70(9):3687-96. PubMed ID: 20430760 [TBL] [Abstract][Full Text] [Related]
10. Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections. Kim B; Yang Q; Chan LW; Bhatia SN; Ruoslahti E; Sailor MJ Nanoscale Horiz; 2021 Apr; 6(4):330-340. PubMed ID: 33599221 [TBL] [Abstract][Full Text] [Related]
11. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery. Kim B; Park JH; Sailor MJ Adv Mater; 2019 Dec; 31(49):e1903637. PubMed ID: 31566258 [TBL] [Abstract][Full Text] [Related]
12. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications. Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511 [TBL] [Abstract][Full Text] [Related]
13. SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression. Yuan H; Huang X; Li Q; Luo C; Lin C; Zhang S; Zhang Y; Yan Z; Du N; Liu Z; Jiang H; Chen B Biomed Pharmacother; 2022 Mar; 147():112672. PubMed ID: 35104698 [TBL] [Abstract][Full Text] [Related]
14. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. Bagalkot V; Gao X ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502 [TBL] [Abstract][Full Text] [Related]
15. Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain. Kang J; Joo J; Kwon EJ; Skalak M; Hussain S; She ZG; Ruoslahti E; Bhatia SN; Sailor MJ Adv Mater; 2016 Sep; 28(36):7962-7969. PubMed ID: 27383373 [TBL] [Abstract][Full Text] [Related]
16. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy. Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060 [TBL] [Abstract][Full Text] [Related]
17. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy. Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764 [TBL] [Abstract][Full Text] [Related]
18. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898 [TBL] [Abstract][Full Text] [Related]